$1.130
-0.184 (-16.30%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
PPCB 相似圖表分析預測
Alphio's PPCB stock price prediction model matches the current Propanc Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (-0.49%). The 1-week path is $1.07 (-5.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Propanc Biopharma Inc 股票嗎？
Propanc Biopharma Inc (PPCB) appears to be a good buy right now due to its recent surge of 202.75% after reporting significant tumor growth inhibition of over 90% in advanced pancreatic cancer models. Additionally, the stock has shown a 25% increase over the last five days, indicating positive momentum. However, the main risk is its year-to-date change of -90.55%, suggesting high volatility and potential for further declines if the positive news does not sustain investor interest.
PPCB 股價於 Tuesday 收在 $1.13，此前下跌 -16.30%
Propanc Biopharma Inc (PPCB) last closed at $1.13, losing -16.30%. These facts feed the 1-day and 1-week PPCB price prediction above.
預測驅動因素
Propanc Biopharma Inc（PPCB）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 PPCB 最接近的股票，依相似度排序。
PPCB 季節性分析
Historically the probability of a positive September return for PPCB is 0.00%. August offers the highest probability of a positive month at 31.25%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。